Literature DB >> 2574062

Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurones.

T Yakushiji1, T Fukuda, Y Oyama, N Akaike.   

Abstract

1. The effects of benzodiazepines and non-benzodiazepine compounds on the gamma-aminobutyric acid (GABA)-induced chloride current (ICl) were studied in frog isolated sensory neurones by use of a concentration-jump (termed 'concentration-clamp') technique, under single-electrode voltage-clamp conditions. The drugs used were classified into four categories as follows: full benzodiazepine receptor agonists (diazepam, clonazepam, nitrazepam, midazolam, clotiazepam and etizolam), partial agonists (CL 218,872, Ro 16-6028, Ro 17-1812 and Ro 23-0364), inverse agonists (Ro 15-3505, FG 7142 and beta-CCE) and a benzodiazepine receptor antagonist, Ro 15-1788 (flumazenil). 2. All full agonists at concentrations of 3 x 10(-6) M or less increased dose-dependently the peak amplitude of ICl elicited by 3 x 10(-6) M GABA to twice to three times larger than the control. However, no further augmentation of the GABA response was observed at concentrations of 1 x 10(-5) M or higher. Partial agonists also showed a dose-dependent augmentation of the GABA response at concentrations ranging from 3 x 10(-8) M to 3 x 10(-5) M, but their efficacies of augmentation of the GABA response were only about half or less of those of full agonists. Of the inverse agonists, beta-CCE had a unique dose-dependent effect on the GABA response. Beta-CCE reduced dose-dependently the GABA response at concentrations of less than 3 x 10(-6) M, but augmented it at concentrations of 3 x 10(-5) M and 6 x 10(-5) M. The inverse agonists reduced dose-dependently the GABA response. The benzodiazepine antagonist, flumazenil, slightly augmented the GABA response at concentrations between 3 x 10 7M and 3 x 10 5 M. 3. These results show clear differences in the effects on the GABA response between these four categories of compounds known to affect the benzodiazepine recognition site of the GABA/ benzodiazepine receptor-chloride channel complex. Our experimental system of frog isolated sensory neurones and a 'concentration-clamp' technique appears to be useful for evaluating efficacy of compounds on responses mediated by the GABA/benzodiazepine receptor-chloride channel complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574062      PMCID: PMC1854765          DOI: 10.1111/j.1476-5381.1989.tb14600.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Benzodiazepine receptor: demonstration in the central nervous system.

Authors:  H Möhler; T Okada
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

Review 2.  Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.

Authors:  E Costa; A Guidotti; C C Mao
Journal:  Adv Biochem Psychopharmacol       Date:  1975

3.  In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.

Authors:  J C Blanchard; A Boireau; C Garret; L Julou
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

Review 4.  Anxioselective anxiolytics.

Authors:  M Williams
Journal:  J Med Chem       Date:  1983-05       Impact factor: 7.446

5.  Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum.

Authors:  J C Blanchard; L Julou
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

6.  Internal perfusion studies demonstrating GABA-induced chloride responses in frog primary afferent neurons.

Authors:  K Hattori; N Akaike; Y Oomura; S Kuraoka
Journal:  Am J Physiol       Date:  1984-03

7.  A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone.

Authors:  P Polc; E P Bonetti; R Schaffner; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

Review 8.  Benzodiazepine receptors: cellular and behavioral characteristics.

Authors:  A S Lippa; D Critchett; M C Sano; C A Klepner; E N Greenblatt; J Coupet; B Beer
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

9.  Sodium-dependent suppression of gamma-aminobutyric-acid-gated chloride currents in internally perfused frog sensory neurones.

Authors:  N Akaike; T Maruyama; S K Sikdar; S Yasui
Journal:  J Physiol       Date:  1987-11       Impact factor: 5.182

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  10 in total

1.  CGP-37157 inhibits the sarcoplasmic reticulum Ca²+ ATPase and activates ryanodine receptor channels in striated muscle.

Authors:  Jake T Neumann; Paula L Diaz-Sylvester; Sidney Fleischer; Julio A Copello
Journal:  Mol Pharmacol       Date:  2010-10-05       Impact factor: 4.436

Review 2.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

3.  Potentiation by sevoflurane of the gamma-aminobutyric acid-induced chloride current in acutely dissociated CA1 pyramidal neurones from rat hippocampus.

Authors:  J Wu; N Harata; N Akaike
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Drug Alcohol Depend       Date:  2010-08-30       Impact factor: 4.492

Review 5.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

6.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.

Authors:  J W Mandema; M T Kuck; M Danhof
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

7.  Differential properties of type I and type II benzodiazepine receptors in mammalian CNS neurones.

Authors:  T Yakushiji; T Shirasaki; M Munakata; A Hirata; N Akaike
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor.

Authors:  G Puia; I Ducic; S Vicini; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Non-competitive inhibition of GABAA responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones.

Authors:  T Yakushiji; T Shirasaki; N Akaike
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

10.  Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities.

Authors:  Shaotong Zhu; Akshay Sridhar; Jinfeng Teng; Rebecca J Howard; Erik Lindahl; Ryan E Hibbs
Journal:  Nat Commun       Date:  2022-08-06       Impact factor: 17.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.